Humana (HUM ) Tops Q2 EPS by 4c, Reaffirms FY EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Humana Reports Second Quarter 2015 Financial Results; Reaffirms 2015 Financial Guidance
July 29, 2015 7:30 AM EDT2Q 2015 EPS of $2.85 includes $1.18 of gain related to sale of Concentra 2Q 2015 Adjusted EPS of $1.67 excludes the Concentra 2Q 2015 gain and compares to managements guidance of $1.60 to $1.65 Reaffirmed full-year 2015 EPS guidance of approximately $9.28 or $7.75 on an Adjusted basis (excluding the year-to-date gain on sale of Concentra of $1.53 per share) 2Q 2015 Medicare Advantage utilization seen as stabilizing and tracking with managements revised expectations Actions taken to improve profitability of individual commercial and state-based contracts businesses
... More
